As it is well documented that the tumour-suppressor let-7 family regulates KRAS in pancreatic [51], [52], lung [53], colon [54] and breast cancers [55], we concentrated on miR-126 as a novel KRAS targeting miRNA in PDAC. This evidence concerns the gene KRAS and neoplasm.